BioPartners conducts research across a wide range of respiratory conditions — including asthma, COPD, bronchitis, RSV, influenza, COVID-19, and other acute or chronic pulmonary diseases.
We offer a controlled clinical environment ideal for evaluating respiratory diagnostics, usability studies for point-of-care devices, device performance comparisons, and therapeutic monitoring programs. Our workflows support efficient symptom-driven recruitment, enabling rapid enrollment of both acute and chronic respiratory patients.
Our teams are trained to perform multi-swab collections, nasopharyngeal and oropharyngeal procedures, repeat sampling, symptom logs, spirometry (optional), and device usability assessments based on sponsor requirements.
We ensure strict adherence to sample-handling procedures to maintain biomarker stability and diagnostic accuracy.
Our integrated CRO model allows real-time oversight, minimizing deviations and enabling sponsors to receive clean, inspection-ready datasets.
Whether the objective is assay validation, viral load correlations, device usability testing, or biomarker evaluation, BioPartners provides the operational expertise and clinical discipline needed for high-quality respiratory research.